Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.

MLA

van Kwawegen, Calvin B., et al. “Genetic Variants, Thrombocytopenia, and Clinical Phenotype of Type 2B von Willebrand Disease: A Median 16-Year Follow-up Study.” Journal of Thrombosis and Haemostasis : JTH, vol. 22, no. 12, Dec. 2024, pp. 3460–72. EBSCOhost, https://doi.org/10.1016/j.jtha.2024.08.028.

APA

van Kwawegen, C. B., Atiq, F., Endenburg, D., Fijnvandraat, K., van Galen, K. P. M., Cnossen, M. H., Schols, S. E. M., Kruip, M. J. H. A., van Heerde, W. L., de Meris, J., van der Bom, J. G., Eikenboom, J., Meijer, K., & Leebeek, F. W. G. (2024). Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study. Journal of Thrombosis and Haemostasis : JTH, 22(12), 3460–3472. https://doi.org/10.1016/j.jtha.2024.08.028

Chicago

van Kwawegen, Calvin B, Ferdows Atiq, Dara Endenburg, Karin Fijnvandraat, Karin P M van Galen, Marjon H Cnossen, Saskia E M Schols, et al. 2024. “Genetic Variants, Thrombocytopenia, and Clinical Phenotype of Type 2B von Willebrand Disease: A Median 16-Year Follow-up Study.” Journal of Thrombosis and Haemostasis : JTH 22 (12): 3460–72. doi:10.1016/j.jtha.2024.08.028.